**Abstract**

Negative symptoms are highly resistant to available treatments despite its close association with functional outcome in schizophrenia. Clinical Assessment Interview for Negative Symptoms (CAINS) has been recently developed to improve its measurement and is considered promising negative symptoms instrument with sound psychometric properties. In the current study, we performed multi-site studies to validate the Korean version of the CAINS. One hundred eighty schizophrenia patients diverse in age, symptoms, and illness duration were recruited from four mental clinics. The Korean version of the CAINS, the Scale for the Assessment of Negative Symptoms (SANS), Brief Psychiatric Rating Scale (BPRS), Calgary Depression Scale for Schizophrenia (CDSS), self-report measure of behavioral inhibition and activation (BIS/BAS) and neurocognitive tasks were administered. The Korean CAINS demonstrated high internal-consistency and inter-rater agreement. Exploratory Factor Analysis replicated two-factor structure of the original scale which includes motivation/pleasure and expression deficits. No gender difference was found on the Korean CAINS scores. The Korean CAINS showed adequate convergent validity with the total and subscale scores of the SANS, negative symptoms of BPRS, and self-report measure of behavioral activation. The Korea CAINS also exhibited strong divergent validity as it was minimally related with positive symptoms of the BPRS, depression in the CDSS, and verbal fluency test among neurocognitive tasks. The Korean version of the CAINS demonstrated good reliability and validity and is expected to facilitate studies on the etiology, mechanism, and treatment of negative symptoms in Korean schizophrenia patients.
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